NATURE’S SUNSHINE PRODUCTS, INC. Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent of $9.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-05.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent · last filed 2012-03-05
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for fiscal 2011 was $9.00K, a 350.00% increase from fiscal 2010.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for fiscal 2010 was $2.00K, a 95.24% decline from fiscal 2009.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for fiscal 2009 was $42.00K.
| Period end | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent 12 month |
|---|---|
| 2011-12-31 | $9.00K 10-K · filed 2012-03-05 |
| 2010-12-31 | $2.00K 10-K · filed 2012-03-05 |
| 2009-12-31 | $42.00K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |